Literature DB >> 27188952

Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.

Sirwan K L Darweesh, Peter J Koudstaal, Bruno H Stricker, Albert Hofman, M Arfan Ikram.   

Abstract

We investigated trends in the incidence of parkinsonism and Parkinson disease (PD) by comparing data from the first 2 subcohorts of the Rotterdam Study, a prospective, population-based cohort study (first subcohort: baseline 1990 with 10 years of follow-up; second subcohort, baseline 2000 with 10 years of follow-up). From the baseline years, we observed differences in the second subcohort that were associated with a lower risk of PD for some but not all baseline risk factors. Participants in both subcohorts were followed for a maximum of 10 years and monitored for the onset of parkinsonism, the onset of dementia, or death, until January 1, 2011. We used Poisson regression models to compare the incidences of parkinsonism, both overall and by cause (PD and secondary causes), and competitive events (incident dementia and death) as well as the mortality of parkinsonism patients in the 2 subcohorts. In the 1990 subcohort, there were 182 cases of parkinsonism (84 of which were PD) during 57,052 person-years. In the 2000 subcohort, we observed 28 cases of parkinsonism (10 with PD) during 22,307 person-years. The overall age- and sex-adjusted incidence of parkinsonism was lower in the 2000 subcohort (incidence rate ratio = 0.55, 95% confidence interval: 0.36, 0.81), and PD incidence declined sharply (incidence rate ratio = 0.39, 95% confidence interval: 0.19, 0.72). Competitive event rates were lower in the 2000 subcohort, and mortality rates among persons with parkinsonism remained stable. These findings suggest that the incidence of parkinsonism in general, and of PD in particular, decreased between 1990 and 2011.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Parkinson disease; cohort study; incidence studies

Mesh:

Substances:

Year:  2016        PMID: 27188952     DOI: 10.1093/aje/kwv271

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

Review 1.  Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy.

Authors:  Fauzia Nazam; Sibhghatulla Shaikh; Nazia Nazam; Abdulaziz Saad Alshahrani; Gulam Mustafa Hasan; Md Imtaiyaz Hassan
Journal:  Mol Cell Biochem       Date:  2021-03-09       Impact factor: 3.396

2.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

3.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

4.  The future burden of Parkinson's disease.

Authors:  Walter A Rocca
Journal:  Mov Disord       Date:  2017-08-07       Impact factor: 10.338

5.  Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Authors:  Sirwan K L Darweesh; Frank J Wolters; Ronald B Postuma; Bruno H Stricker; Albert Hofman; Peter J Koudstaal; M Kamran Ikram; M Arfan Ikram
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

Review 6.  Epidemiology of Parkinson's Disease-East Versus West.

Authors:  Masoom M Abbas; Zheyu Xu; Louis C S Tan
Journal:  Mov Disord Clin Pract       Date:  2017-12-22

7.  Parkinson Matters.

Authors:  Sirwan K L Darweesh; Karen G Raphael; Patrik Brundin; Helen Matthews; Richard K Wyse; Honglei Chen; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

8.  Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2018-10-01       Impact factor: 44.182

9.  Professional occupation and the risk of Parkinson's disease.

Authors:  S K L Darweesh; M K Ikram; M J Faber; N M de Vries; C A Haaxma; A Hofman; P J Koudstaal; B R Bloem; M A Ikram
Journal:  Eur J Neurol       Date:  2018-08-06       Impact factor: 6.089

10.  Identifying incident Parkinson's disease using administrative diagnostic codes: a validation study.

Authors:  Brett J Peterson; Walter A Rocca; James H Bower; Rodolfo Savica; Michelle M Mielke
Journal:  Clin Park Relat Disord       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.